Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $2.97M.
ENTERPRISE VALUE (EV)
$2.97M
Basel Medical Group Ltd Ordinary Shares
Market Cap
$5.26M
Enterprise Value (EV)
$2.97M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Basel Medical Group Ltd Ordinary Shares (BMGL) | $5.26M | $2.97M |
| Imunon, Inc. (IMNN)vs › | $5.21M | $6.19M |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.36M | $3.78M |
| Alzamend Neuro Inc (ALZN)vs › | $5.36M | N/A |
| Gelteq Limited Ordinary Shares (GELS)vs › | $4.99M | $8.40M |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.54M | $3.37M |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.59M | N/A |
| CalciMedica, Inc. (CALC)vs › | $4.85M | N/A |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.80M | $1.01M |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.58M | $1.19M |
Market Cap
$5.26M
Total Debt
$48243.74
Cash
$2.34M
Enterprise Value
$2.97M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
